Daily Command replaces disconnected data silos and point solutions with a single command layer. At the center is Semmelweis, a specialized AI model that processes Clinical Intent Signals to detect prescribing intent in real time. Unlike general-purpose AI, this model is built specifically for pharmaceutical workflows, integrating with over 185 electronic health record systems to map physician decisions without accessing patient-level data.

Developed with input from 75 industry leaders, the platform includes an analytics workbench that allows manufacturers to merge first-party data with clinical intent and outcome signals. This structure aims to shrink the gap between data collection and execution. Early beta results suggest the system can drive a 1.4x lift in prescriptions among targeted specialists while significantly reducing the administrative hours required for campaign management. The platform remains interoperable, supporting connections to generative AI tools like ChatGPT and Claude while keeping all actions within medical and regulatory compliance boundaries.